Promising applications of D-amino acids in periprosthetic joint infection

Matthew Caldwell1, Megan Hughes2, Fei Wei1

  • 1Biionix Cluster & College of Medicine, University of Central Florida, 6900 Lake Nona Blvd, Orlando, FL, 32827, USA.

Bone Research
|March 9, 2023
PubMed

Insights

Dextrorotatory-isoforms of amino acids (D-AAs) show promise in combating periprosthetic joint infections (PJIs) by disrupting bacterial biofilms. Further research into D-AA bioengineering could lead to novel prevention and treatment strategies for PJIs following total joint arthroplasty.

Area of Science:

  • Biomedical Engineering
  • Infectious Diseases
  • Orthopedic Surgery

Background:

  • Aging populations are increasing demand for total joint arthroplasty (TJA), leading to a projected rise in periprosthetic joint infections (PJIs).
  • Microbial biofilm formation presents a significant challenge in preventing and treating PJIs, despite advancements in surgical protocols.
  • Dextrorotatory-isoforms of amino acids (D-AAs) are crucial for bacterial cell wall integrity and have demonstrated antimicrobial properties.

Purpose of the Study:

  • To review the emerging role of D-AAs in the context of total joint arthroplasty (TJA).
  • To explore the potential of D-AAs in preventing and treating periprosthetic joint infections (PJIs) by targeting biofilms.
  • To highlight D-AAs as novel therapeutic targets for PJI management.

Main Methods:

  • Literature review examining existing data on D-AAs and their effects on bacterial biofilms.
  • Analysis of D-AA properties relevant to bacterial adhesion, biofilm formation, and disassembly.
  • Exploration of D-AA's potential impact on host bone tissue response in the context of TJA.

Main Results:

  • Exogenous administration of D-AAs has shown efficacy in preventing bacterial adhesion and biofilm formation on abiotic surfaces.
  • D-AAs demonstrate substantial potential in promoting the disassembly of established microbial biofilms.
  • The specific role of D-AAs in disrupting PJI biofilms and influencing host bone tissue response requires further investigation.

Conclusions:

  • D-AAs represent a promising novel strategy for combating bacterial biofilms associated with periprosthetic joint infections (PJIs).
  • D-AA bioengineering may offer a future therapeutic approach for the prevention and treatment of PJIs after total joint arthroplasty (TJA).
  • Further research is warranted to fully elucidate the mechanisms and applications of D-AAs in PJI management.